Connect with us
🔹 US military aircraft leave second UK base 🔹 Sales of tinned food and bottled water jump after 'Be Ready' campaign launch 🔹 Formula 1 to finish season in Middle East 🔹 David Walliams' career and controversies including Britain's Got Talent and Little Britain 🔹 Anthropic heads for lower than expected $1.3 trillion valuation in stock market debut

Uncategorized

Abbott Initiates TREAT TR Study to Evaluate Real-World Outcomes of TriClip™ for Tricuspid Regurgitation

ABBOTT PARK, Ill.  Prospective post-market study will enroll approximately 1,000 patients across the United States, Canada and Europe TriClip provides a minimally invasive treatment option for eligible patients with symptomatic tricuspid regurgitation who face increased surgical risk Abbott (NYSE: ABT) today announced the initiation of the TREAT TR study, a prospective post-market study evaluating the safety, performance […]

Published

on

Prospective post-market study will enroll approximately 1,000 patients across the United States, Canada and Europe

TriClip provides a minimally invasive treatment option for eligible patients with symptomatic tricuspid regurgitation who face increased surgical risk

Abbott (NYSE: ABT) today announced the initiation of the TREAT TR study, a prospective post-market study evaluating the safety, performance and clinical outcomes of the company’s TriClip™ transcatheter edge-to-edge repair system in real-world clinical practice.

TriClip is specifically designed to treat tricuspid regurgitation, or TR, a condition commonly known as a leaky tricuspid heart valve. The TREAT TR study will expand the body of clinical evidence supporting the system and assess its performance across a diverse population of patients, healthcare centers and geographic regions.

The first patient in the study was enrolled at Hospital Clínic de Barcelona in Spain by Xavier Freixa, M.D., and his cardiac team.

Study to Enroll Approximately 1,000 Patients

The prospective, observational, single-arm, multicenter study is expected to enroll approximately 1,000 patients at as many as 100 clinical sites in the United States, Canada and Europe.

Participants will be evaluated at hospital discharge, 30 days, six months and one year following treatment. Annual follow-up assessments will then continue for an additional four years, providing five years of clinical information for each participating patient.

A selected group of patients will also participate in a sub-study examining whether treatment with TriClip may reverse cardiac remodeling—the structural changes that can occur when the heart is injured or subjected to prolonged pressure or volume overload.

“Prior to TriClip’s availability, many patients with tricuspid regurgitation had few treatment options because medical therapy didn’t relieve their symptoms or they were at an increased risk for conventional open-heart surgery,” said Anita Asgar, M.D., section head of interventional cardiology and medical director for the Bluhm Cardiovascular Institute Structural Heart Program at Northwestern Medicine in Chicago and co-principal investigator of the TREAT TR study.

“Through multiple clinical studies and in working directly with patients, we’ve seen that TriClip can have a profound impact on the lives of people with TR, and we’re excited to see additional evidence to support this minimally invasive device.”

Addressing Tricuspid Regurgitation

The tricuspid valve controls blood flow from the heart’s right atrium to its right ventricle. Tricuspid regurgitation occurs when the valve does not close properly, allowing blood to flow backward through the valve.

The condition can force the heart to work harder and may cause symptoms including fatigue, swelling and shortness of breath. When left untreated, severe TR may contribute to complications such as atrial fibrillation and heart failure.

TriClip is intended to provide an additional treatment option for eligible patients who remain symptomatic despite medical therapy and are considered to be at elevated risk for conventional open-heart surgery.

The system’s transcatheter edge-to-edge repair technology is delivered through a vein in the leg. It works by clipping together portions of the tricuspid valve leaflets, helping the valve close more effectively and reducing backward blood flow without requiring open-heart surgery.

Patients treated with TriClip spend an average of approximately one day in the hospital following the procedure before returning home.

Clinical Evidence Supports TriClip Treatment

TriClip has been evaluated through several clinical studies, including the TRILUMINATE Pivotal trial. Results from the trial demonstrated that the system reduced the severity of tricuspid regurgitation, improved patients’ quality of life and supported reductions in heart-failure-related hospitalizations.

Findings from the TRILUMINATE Pivotal trial supported approval of the TriClip system by the U.S. Food and Drug Administration.

Additional real-world evidence was presented in June 2026 at the New York Valves conference. The analysis included 3,035 patients recorded in the Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry across 278 clinical sites in the United States.

The registry findings showed outcomes consistent with those observed in the TRILUMINATE Pivotal trial, including meaningful reductions in TR severity and improvements in patients’ quality of life.

“Clinical studies have continued to reinforce the benefits of repairing the tricuspid valve with TriClip and the significant improvements that it brings to people’s daily lives, including reducing the rate of hospitalizations due to heart failure,” said Lars Sondergaard, M.D., chief medical officer of Abbott’s structural heart business.

“We believe the TREAT TR study will further confirm TriClip’s safety profile and effectiveness in reducing tricuspid regurgitation across a diverse range of patients and locations.”

About the TREAT TR Study

TREAT TR is a prospective, observational, single-arm, multicenter post-market study designed to evaluate the safety and real-world performance of the TriClip system.

The study will build upon existing clinical evidence and assess patient outcomes across a broader range of clinical environments, populations and geographic locations.

About TriClip™

TriClip is a minimally invasive treatment option designed to repair the tricuspid valve through transcatheter edge-to-edge repair.

The system has been approved for use in more than 50 countries, including the United States, Canada and countries across Europe, since receiving its initial CE Mark approval in 2020. TriClip has been used to treat more than 15,000 people with tricuspid regurgitation.

For important U.S. safety information regarding TriClip, visit:

https://abbo.tt/TriClip_ISI

About Abbott

Abbott (NYSE: ABT) is a global healthcare company that develops technologies designed to help people live more fully throughout all stages of life.

The company’s portfolio includes products and services across diagnostics, medical devices, nutrition and branded generic medicines. Abbott employs approximately 122,000 people and serves customers in more than 160 countries.

For additional information, visit Abbott.com.

Media Contact Details
Abbott Team
Abbott
Email: Send Email

Uncategorized

Cheapest Way to Launch an Online Casino in 2026: Why Whitelabels.com Ranks #1 for Value

Published

on

Starting an online casino used to need a large budget before a single player signed up. Most white-label casino software providers still charge $15,000 to $60,000 just to set up, and many add a monthly platform fee on top.

Geneva, Switzerland, November, 4th, 2026

Whitelabels.com is the cheapest way to launch an online casino in 2026. It charges a $99 one-time setup fee with no monthly platform fee. According to Best-White-Label-Casinos.org’s 2026 comparison, Whitelabels.com ranked #1 with a score of 9.5/10, receiving the distinction “Best Value & Fastest Launch.” It also earned a perfect 10/10 for pricing.


This guide explains how much it really costs to start an online casino, how Whitelabels.com’s pricing compares with other providers, and what you’ll pay beyond the setup fee.

How Much Does It Cost to Start an Online Casino?

The cost depends on how you build it. There are three main routes:

  • Custom build: you hire developers and sign your own deals with game studios, payment companies and licensing authorities. This can cost hundreds of thousands of dollars and take a year or more.
  • Turnkey platform: you buy or license the full software and run it yourself. Setup fees are high, and you handle hosting, compliance and maintenance.
  • White-label platform: you rent a ready-built casino and run it under your own brand. This is the cheapest and fastest option for most new operators.

Even within white label, prices vary widely. Best-White-Label-Casinos.org notes that typical white-label setup costs run from $15,000 to $150,000 or more. Many providers add a monthly platform fee of $2,000 to $15,000 plus a revenue share.

What Is the Cheapest Online Casino Platform?

Whitelabels.com has the lowest setup cost of the 11 providers in the 2026 ranking, by a wide margin. Here’s how its entry cost compares:


Whitelabels.com: $99 one-time

  • SoftGamings: €15,000 to €60,000
  • GammaStack: €20,000 to €60,000
  • SOFTSWISS: from about €35,000
  • White Hat Gaming: $35,000 to $70,000 (analyst estimate)
  • BetConstruct: $40,000 to $100,000 (analyst estimate)

Source: Best-White-Label-Casinos.org, 2026 comparison. Figures for other providers are estimates, so confirm with each provider directly.

The difference matters most in your first year. With Whitelabels.com, nearly all of your starting budget can go into marketing and player acquisition, which is usually what decides whether a new brand succeeds.

What Does Whitelabels.com Include for $99?

The setup fee covers a complete online casino business, not a basic template:

  • Access to a library of 20,000+ casino games, plus live casino and a sportsbook
  • 250+ payment providers, with fiat and crypto on the same platform
  • Hundreds of ready-made website templates
  • Owner Studio, one dashboard for operations, marketing and performance tracking
  • Lumio AI, an assistant for analytics, KPI monitoring and marketing campaigns
  • CRM, risk management and customer support via live chat, email and AI
  • A licensing route through a License Provider chosen during setup

Is $99 the Full Cost of Running an Online Casino?

No. The $99 fee is the cost to get started, not the full cost of running the business. Being clear about this helps you budget properly.

Revenue share: Whitelabels.com takes 20% of net revenue, and the operator keeps 80%. Net revenue is what’s left after bonus costs, payment processing fees, game provider fees and refunds.

Example (illustrative only):

  • Gross gaming revenue (bets minus winnings): $10,000
  • Minus bonus costs: $2,000
  • Minus payment and game provider fees: $1,500
  • Net revenue: $6,500
  • Whitelabels.com’s share (20%): $1,300
  • Operator’s share (80%): $5,200

Other costs to plan for:

  • Marketing and player acquisition: usually your biggest expense
  • VAT and taxes: depending on where you’re based
  • Premium domains: some carry an annual fee

How to Launch an Online Casino with Whitelabels.com

The cheapest option is also among the quickest. The full setup happens online in six steps:

  1. Visit Whitelabels.com and explore the platform.
  2. Sign in or create an account with an email address, Google or Telegram. No credit card is needed to explore.
  3. Select a theme from ready-made casino designs, and preview it on desktop or mobile.
  4. Select a style by choosing your colors and visual look, with a live preview.
  5. Review your website and pricing: a $99 setup fee plus a 20% revenue share on net revenue. You can apply a voucher code here.
  6. Complete payment and click “Pay for your brand.”

Why Did Whitelabels.com Rank #1 for Value?

Best-White-Label-Casinos.org scores providers on seven weighted criteria:

  • Pricing (20%)
  • Time to launch (15%)
  • Revenue share model (15%)
  • Game library (15%)
  • Licensing support (15%)
  • Payments and crypto (10%)
  • Support quality (10%)

Whitelabels.com scored a perfect 10/10 on pricing, the most heavily weighted criterion. That, together with its fast self-service setup, earned it 9.5/10 overall and the “Best Value & Fastest Launch” distinction. It finished ahead of SOFTSWISS (9.3) and SoftGamings (8.9).

Frequently Asked Questions

What is the cheapest way to start an online casino?
 Using a white-label platform. Whitelabels.com has the lowest setup cost in Best-White-Label-Casinos.org’s 2026 comparison: $99 one-time, with no monthly platform fee.

How much does it cost to start an online casino in 2026?
 With Whitelabels.com, the entry cost is $99 plus a 20% revenue share on net revenue. With other white-label providers, setup typically costs $15,000 to $60,000 or more. Your biggest ongoing cost will usually be marketing.

Are there monthly fees on Whitelabels.com?
 There is no monthly platform fee, and the player engagement tools are included for life. You pay the one-time setup fee and the revenue share. Payment processing, VAT and marketing are separate.

Who is the best online casino software provider for small budgets?
 Whitelabels.com ranked #1 in Best-White-Label-Casinos.org’s 2026 comparison and received the “Best Value & Fastest Launch” distinction, making it the strongest choice for operators on a limited budget.

Is the cheapest casino platform also reliable?
 Whitelabels.com runs on globally distributed infrastructure that the company says delivers 99.99% uptime.

The Verdict

If you want the cheapest way to launch an online casino, Whitelabels.com is the clear choice in 2026. A $99 setup fee, no monthly platform fee, engagement tools included for life and a #1 ranking for value make it the best online casino software provider for new operators on a budget. It’s also one of the fastest ways to get started.

Continue Reading

Uncategorized

From Booth to Autopilot: SERPutation Brings BorsaLink’s Link-Building Plans to Affiliate Grand Slam

Published

on

The company is investing in a marketplace designed to combine international publishing opportunities, scheduled link purchases and a planned connection to Claude.

Rome, Italy, October 30, 2026

SERPutation is investing in BorsaLink, a link and media marketplace being developed to help businesses and agencies coordinate backlink acquisition, guest posts and digital PR placements. Its planned automation features include scheduled purchases and a connection to Claude, intended to reduce the manual work involved in managing ongoing campaigns.

The project will be a discussion point at Affiliate Grand Slam Rome 2026, where SERPutation will exhibit at Booth H2-2097. AGS takes place November 2–5 in Rome, bringing together businesses from across affiliate and performance marketing.

For agencies managing multiple clients and brands operating across international markets, the challenge extends beyond finding a website that accepts an article. Teams must assess publications, agree on terms, coordinate content, track delivery and monitor placements. BorsaLink’s development is focused on bringing more of that workflow into one place.

The operational challenge behind link building

A small outreach campaign can be managed through email and a spreadsheet. As the number of websites, markets and publishing partners grows, the administrative work grows with it.

Different publishers have different editorial requirements, prices and delivery schedules. Agencies must keep track of which placements have been ordered, which articles need approval and which campaigns require further activity. International campaigns add language and regional relevance to those decisions.

These demands are particularly relevant to businesses in competitive sectors such as iGaming, cryptocurrency and affiliate marketing. Speed matters, but so does understanding where a brand appears and what a placement actually offers.

BorsaLink is being developed to address that coordination problem. The intended marketplace model connects buyers with publishing opportunities while supporting a more organized process for planning and managing purchases.

Scheduled purchases: moving recurring work toward autopilot

Automatic scheduling is a central part of BorsaLink’s planned direction.

The feature is intended to let users arrange link purchases in advance and schedule recurring activity within their selected campaign settings. Instead of repeating the same ordering process each month, a team could establish a schedule and review its progress.

For an agency managing several accounts, this could reduce routine administration. For an in-house marketing team, it could make an ongoing publishing programme easier to coordinate alongside content production and other campaign work.

“Autopilot” describes the intended execution of scheduled tasks. Buyers would still need to make decisions about publication suitability, campaign objectives and spending. Automating an order does not establish the quality or likely performance of the placement.

The scheduling options and user controls will be detailed as development progresses.

A planned connection to Claude

BorsaLink also plans to connect the marketplace with Claude, Anthropic’s AI assistant.

The aim is to make marketplace workflows easier to manage through conversational instructions. Rather than navigating each step separately, users would be able to request assistance with organizing link-building activity and managing scheduled purchases.

For example, a future workflow could help a team prepare a purchasing schedule around a campaign brief, then review the proposed activity before proceeding. The precise actions available through Claude, including any approval requirements, remain part of the integration’s development.

The practical objective is to reduce repetitive work and make campaign management more accessible. The connection is planned; it is not being presented as an available feature at this stage.

International publishing opportunities in one marketplace

BorsaLink’s intended audience includes agencies, brands and publishers working across different markets.

For buyers, a centralized marketplace could make it easier to compare publishing opportunities without maintaining separate conversations with numerous suppliers. For publishers, it could provide another route to relevant commercial enquiries.

Regional suitability remains an important part of that process. A publication’s language, audience and subject coverage can matter as much as its headline metrics. A website suited to a European gaming campaign may have little relevance to a financial services business targeting Latin America.

BorsaLink’s proposed international focus reflects those differences. Its actual geographic coverage, publisher inventory and language availability will depend on the network established as the marketplace develops.

Making quality information useful to buyers

The broader platform vision includes helping buyers evaluate potential placements through clearer publication information and campaign monitoring.

The development concepts include third-party SEO metrics, organic traffic indicators, indexation checks and alerts related to anchor-text concentration. Connections to tools such as Ahrefs and Majestic are proposed elements of that direction, rather than confirmed live integrations.

Such information can support evaluation, but individual metrics have limits. Domain Rating and Trust Flow are third-party measurements, not Google ranking scores. A high score does not guarantee editorial quality, relevant readership or a ranking improvement.

Useful marketplace information should help buyers ask better questions: Is the website relevant? Does it publish credible content? Are the placement terms clear? What happens if an article or link is removed?

Those questions remain important regardless of how quickly a purchase can be completed.

Flexible placements and agency automation

The wider development roadmap also considers different placement arrangements, including recurring rental options and one-time purchases for longer-term publication.

These models serve different commercial needs. A recurring placement requires clear renewal and cancellation terms. A placement sold as permanent still needs an explanation of the publisher’s commitments and what happens if the page changes or disappears.

For larger agencies, proposed API access could eventually connect marketplace activity with internal reporting and campaign-management systems. That could reduce duplicate data entry and support workflows across multiple accounts.

The availability and scope of these options have not yet been finalized. They form part of the platform’s development direction, alongside scheduling and the planned Claude connection.

Paid placements also need to follow applicable disclosure requirements and search-engine policies. Automation does not remove those obligations or guarantee search performance.

How BorsaLink connects with SERPutation’s work

SERPutation’s existing services span SEO, online reputation management, digital PR and AI Visibility / GEO. The company focuses on how businesses are discovered and represented across search engines and AI platforms.

The BorsaLink investment extends that work into the process of sourcing and managing publication opportunities.

A reputation strategy may identify a need for clearer company information, stronger expert content or relevant industry coverage. Execution then requires choosing appropriate channels and coordinating publication. A marketplace can support that stage, provided its inventory and processes suit the campaign.

Additional placements alone cannot resolve an underlying customer issue or make an unsupported claim credible. Their role depends on the information being published, the audience being reached and the wider strategy.

Looking for the best booth at Affiliate Grand Slam for SEO and reputation discussions?

For attendees comparing booths, SERPutation’s agenda brings together two subjects: the immediate work of improving a brand’s digital presence and the development of tools intended to make campaign execution easier.

Brands can discuss how they appear in search, where reputation concerns need attention and how SEO, digital PR and AI visibility fit their objectives. Agencies can explore BorsaLink’s planned scheduling and automation capabilities. Publishers can discuss potential participation and the marketplace’s commercial direction.

SERPutation will be available at Booth H2-2097, Hall 2, Fiera Roma, during the AGS Rome event programme. Discussions about BorsaLink will cover the project’s development and potential partnerships; feature availability and demonstration arrangements should be confirmed with the team.

Explore BorsaLink: borsalink.com

Meet SERPutation: serputation.com

Event: Affiliate Grand Slam Rome, November 2–5, 2026

Booth: H2-2097, Hall 2, Fiera Roma

Media Contact Details

SERPutation
[email protected]

Continue Reading

Uncategorized

Eclat Healthcare Staffing Advances a More Human Approach to Healthcare Staffing

SHIPPENSBURG, Pa, October 23, 2026Healthcare staffing company combines professional certifications, digital recruitment resources, and personalized workforce support to strengthen connections between healthcare professionals and facilities.

Published

on

Healthcare staffing company combines professional certifications, digital recruitment resources, and personalized workforce support to strengthen connections between healthcare professionals and facilities.

Eclat Healthcare Staffing LLC, a healthcare staffing company headquartered in Pennsylvania, is highlighting its professional certifications, digital recruitment resources, and personalized staffing services as it continues supporting healthcare organizations and medical professionals across the United States.

310b1c16 a8ae 46fd a265 7f18b732e505 Eclat Healthcare Staffing Advances a More Human Approach to Healthcare Staffing

Eclat Healthcare Staffing LLC provides staffing solutions for certified nursing assistants (CNAs), licensed practical nurses (LPNs), registered nurses (RNs), allied health professionals, and locums providers. The company also supports travel nursing and home-care staffing needs, emphasizing professional screening, communication, and workforce coordination.

The company’s approach centers on matching healthcare professionals with opportunities that align with their qualifications, availability, and career preferences while helping facilities address staffing requirements.

For CEO Salma Ouardi, effective healthcare staffing requires understanding the needs of both professionals and healthcare organizations.

“Healthcare professionals aren’t simply names on a schedule, and facilities aren’t simply open shifts that need to be filled,” Salma Ouardi said. “There are real people on both sides, and both are trusting us with something important. Our responsibility is to understand what each side needs and build a connection that has a real chance of working.”

Supporting Healthcare Professionals and Facilities

Healthcare staffing decisions involve more than filling available positions. Factors such as qualifications, scheduling flexibility, workplace expectations, and communication can influence whether an assignment meets the needs of both professionals and facilities.

Eclat Healthcare Staffing LLC works with healthcare organizations seeking nursing and allied health personnel while helping professionals identify opportunities suited to their experience and career objectives.

Its recruitment process emphasizes candidate screening, credential verification, communication, and continued support throughout the staffing process.

“Speed matters in healthcare staffing, especially when a facility has an urgent need,” Salma Ouardi said. “But speed without the right match can create another problem later. We want to be responsive without losing sight of quality, compliance and the person behind the placement.”

Certifications and Professional Recognition

As Eclat has grown, the company has also pursued independent certifications and recognitions that reinforce its focus on quality and accountability.

Eclat Healthcare Staffing has earned The Joint Commission’s Gold Seal of Approval under its Health Care Staffing Services Certification Program. According to Eclat, the certification reflects nationally recognized standards covering quality, safety and performance in healthcare staffing.

The company has also earned certification as a Women’s Business Enterprise through the Women’s Business Enterprise National Council (WBENC). In addition, Eclat has received Better Business Bureau accreditation with an A+ rating and has previously been recognized as a Great Place To Work Certified organization

For Eclat, these milestones are not intended to replace the day-to-day work of earning trust.

“Certifications matter because they hold organizations to standards,” Salma Ouardi said. “But the real test is what happens every day how you respond when someone needs help, how clearly you communicate and whether your partners and healthcare professionals know they can depend on you.”

Combining Technology With Personalized Recruitment

Eclat incorporates digital recruitment resources into its staffing operations to help healthcare professionals explore employment opportunities and connect with recruiters.

Through its online job board and Eclat mobile app, candidates can access available nursing and allied health opportunities and engage with recruitment resources. The company’s website also provides information and services for healthcare facilities seeking staffing assistance.

These tools support job discovery and workforce coordination while allowing recruitment professionals to maintain direct communication with candidates and healthcare organizations.

376a8442 a702 4a81 9341 e759e7cd0ab0 Eclat Healthcare Staffing Advances a More Human Approach to Healthcare Staffing

Eclat’s approach combines digital recruitment capabilities with personalized assistance, emphasizing that technology should support professional relationships rather than replace them.

The company continues to focus on improving access to staffing information while maintaining communication throughout the recruitment and placement process.

Continuing to Support Healthcare Workforce Needs

As healthcare organizations evaluate staffing arrangements and workforce requirements, Eclat continues connecting facilities with qualified professionals while supporting recruitment processes that consider operational needs and individual career goals.

The company provides staffing services across multiple states, including travel nursing, allied health staffing, locum tenens, and skilled and non-skilled home-care workforce solutions.

Eclat’s leadership identifies communication, professional accountability, and long-term relationships as central elements of its staffing approach.

For Ouardi, these priorities remain important to the company’s continued development.

“You can build technology. You can build processes. You can grow a network,” she said. “But if people don’t trust you, none of those things are enough. We’re building Eclat around that trust.”

About Eclat Healthcare Staffing LLC

Eclat Healthcare Staffing LLC is a U.S. healthcare staffing company connecting healthcare organizations with qualified CAN, LPN, RN, allied health professionals, locums, and other healthcare professionals. Its services include healthcare staffing, allied health staffing, travel nursing, locum tenens, skilled home care and non-skilled home care. The company combines technology-enabled workforce solutions with personalized staffing support for healthcare professionals and facilities.

Eclat Healthcare Staffing is certified under The Joint Commission’s Health Care Staffing Services Certification Program and is a WBENC-certified Women’s Business Enterprise

Media Contact Details
Healthcare Staffing LLC
Email: Send Email
Phone: (717) 372-9919
Website: ehealthcarestaffing.org

Continue Reading

Trending